CClinicalTrials.gg
TerminatedNCT04599101Updated Apr 4, 2024Results posted

Nasal Suction in Infants With Bronchiolitis Using a NoseFrida vs. Bulb Syringe

An interventional study of Nose Frida nasal suction device and Bulb syringe nasal suction device in Bronchiolitis and Respiratory Disease, sponsored by William Beaumont Hospitals. Terminated at 1 site in United States. Open to participants aged Up to 18 Months. Per ClinicalTrials.gov, last updated 2024-04-04.

Sponsored by William Beaumont Hospitals · Not applicable, Interventional, and Treatment

Why this study was terminated
Due to difficulty enrolling
Phase
Not applicable
Study type
Interventional
Enrollment
21
Allocation
Randomized
Ages
Up to 18 Months
Sex
All
01

Study summary

This research study will evaluate the difference in effectiveness of nasal suction between two different suction devices (NoseFrida and bulb syringe) in infants that have bronchiolitis. Bronchiolitis (a virus infection that goes into the lungs, which subsequently causes difficulty breathing, difficulty sleeping, and difficulty eating and drinking in children) is a common infection in young children. The caregiver-participants will be supplied with a suction devices (either NoseFrida and bulb syringe suction). The device should be used to clear nasal secretions as needed following discharge from the Emergency Center. The participants will be asked to use either a NoseFrida device or a bulb syringe. Caregivers will monitor how well their baby is breathing, eating/drinking, sleeping and how many times the baby has been seen by a medical provider in the 5 days post discharge from the Emergency Center. Post discharge, caregivers will complete a REDCAP survey asking questions about how their baby has been doing over the first 5 days following hospital discharge. REDCAP survey will be sent day 5 and again on day 7 if not completed. This completes study involvement.

Read the detailed description

Bronchiolitis is common infection in the small airways of the lungs in the pediatric population. It typically affects children under the age of two years during the fall and winter months.Infants with this condition often have a significant amount of nasal drainage and congestion. Infants are known to be obligate nasal breathers. When the nasal secretions block the nasal airway, then breathing, sleeping, and eating/drinking all become very difficult. For this reason it is very important to have a good method of suctioning out the nose and clearing out the secretions. Historically a baby's nose was suctioned with a bulb syringe. These are still commonly used and are given out in the hospital setting, although there are many other types of devices that have been developed recently that are used for suctioning. One of these devices that has become very common among parents now is called the NoseFrida. It is important to evaluate this device and its efficacy compared to the bulb syringe.

This research study will evaluate the difference in effectiveness of nasal suction between two different suction devices (NoseFrida and bulb syringe) in infants that have bronchiolitis. Bronchiolitis (a virus infection that goes into the lungs, which subsequently causes difficulty breathing, difficulty sleeping, and difficulty eating and drinking in children) is a common infection in young children. Patients will be considered for enrollment in the study based on inclusion/exclusion criteria. The patient's caregiver will be supplied with an information sheet, and any questions will be addressed. Those who verbally consent will be enrolled in the study. After parents or guardians (caregivers) provide informed consent for their child, researchers will review the child's medical record for information regarding their history of respiratory distress. The caregiver will then be supplied with a suction device to be used once they are discharged home. The participants will be asked to use a NoseFrida device or a bulb syringe. The device supplied which is instructed to be used will be dependent on the week of enrollment in the study. Education will be given on how to use their respective the suction device devices. Along with the device, a form (Home monitoring form) will be supplied that will outline what should be monitored while using the device, including: number of days after discharge until respiratory symptoms resolve, number of days until the infant is eating/drinking well, and the number of days until the infant is sleeping well. A REDCAP survey will be emailed to participants after 5 days post discharge and again 7 days post discharge if not completed.

The protocol was revised to supply both nasal suction devices to the participants. However, no data was collected under this revised protocol before termination.

02

Conditions studied

  • Bronchiolitis
  • Respiratory Disease

Keywords

  • nasal suction
  • nasal secretions
03

In context

Bronchiolitis

360 studies on the registry are indexed under Bronchiolitis; 43 are open to participants now.

This study's enrollment of 21 is below the median of 80 across 249 interventional studies indexed under Bronchiolitis.

Browse Bronchiolitis studies →

Lead sponsor

William Beaumont Hospitals is the lead sponsor of 111 studies on the registry; none are open to participants now.

Of its 30 completed or terminated interventional studies of FDA-regulated products, 30 (100%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 18 Months
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Infants 18 months of age or younger
  • Evaluated in the Emergency Center at Beaumont, Royal Oak
  • Diagnosis of bronchiolitis, or presenting symptoms that are consistent with this diagnosis, such as cough, difficulty in breathing, wheezing, decreased oral intake, Fever
  • Initial Emergency Center visit for the current illness

Exclusion criteria

Exclusion Criteria:

  • Clinically ill, as defined by: Requiring respiratory support (ex. O2 nasal canula, or HFNC) or Abnormal respiratory rate on most recent measurement, per Pediatric Advanced Life Support (PALS) guidelines: Infant- >53 breaths per minute, Toddler- >37 breaths per minute
  • Any history of structural upper airway disease, including Cleft palate, Tracheomalacia/laryngomalacia or Subglottic stenosis
  • Previously enrolled in the study
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
21 participants (actual)

Study arms

  • Experimental
    Nasal suction device: Nose Frida

    Nose Frida nasal suction device to clear nasal secretions

    Device: Nose Frida nasal suction device

  • Active comparator
    Nasal suction device: Bulb

    Bulb syringe suction device to clear nasal secretions

    Device: Bulb syringe nasal suction device

Interventions

  • DeviceNose Frida nasal suction device

    Caregivers will be given a Nose Frida device to remove the child's nasal secretions.

  • DeviceBulb syringe nasal suction device

    Caregivers will be given a bulb syringe device to remove the child's nasal secretions.

06

What researchers measure

Primary outcomes

  1. Number of Emergency Room Visits

    Number of emergency room visits for the same respiratory illness within 5 days following discharge, measured via caregiver response on Redcap survey

    Time frame: 5 days

  2. Number of Participants Readmitted to Hospital for Respiratory Illness or Dehydration

    Number of participants readmitted to Hospital for respiratory illness or dehydration within 5 days following discharge, measured via caregiver response on Redcap survey

    Time frame: 5 days

Secondary outcomes

  1. Caregiver Device Preference

    In response to "Which device did you prefer?" on caregiver survey, caregiver may select NoseFrida, Bulb Syringe, Both, or Neither.

    Time frame: 5 days

  2. Caregiver Perception of NoseFrida Device Effectiveness

    In response to "Which device was more effective in suctioning your baby's nose?" on caregiver survey, responses using a likert scale (0-NoseFrida less effective, 1-NoseFrida equally effective, 2-NoseFrida more effective). A higher score represents higher caregiver perceived effectiveness of NoseFrida

    Time frame: 5 days

  3. Caregiver Perception of Bulb Device Effectiveness

    In response to "Which device was more effective in suctioning your baby's nose?" on caregiver survey, responses using a likert scale (0-Bulb Syringe less effective, 1-Bulb Syringe equally effective, 2-Bulb Syringe more effective). A higher score represents higher caregiver perceived effectiveness of bulb syringe

    Time frame: 5 days

  4. Number of Days After Discharge Until Respiratory Symptoms Return to Pre-illness Levels

    Number of days after discharge until respiratory symptoms (tachypnea, retractions, increased WOB) return to pre-illness levels.

    Time frame: 7 days

  5. Number of Days After Discharge Until Eating/Drinking Returns to Pre-illness Levels

    Number of days after discharge until eating/drinking returns to pre-illness levels

    Time frame: 7 days

  6. Number of Days After Discharge Until Sleeping Returns to Pre-illness Levels

    Number of days after discharge until sleeping returns to pre-illness levels

    Time frame: 7 days

  7. Parental Satisfaction on Suction Product Efficacy

    Parental satisfaction on a likert scale (1-strongly disagree, 2-disagree, 3-undecided, 4-agree, 5-strongly agree) for the question "Does this product suction babies nose well?"

    Time frame: 7 days

  8. Parental Satisfaction on Ease of Use

    Parental satisfaction on a likert scale (1-strongly disagree, 2-disagree, 3-undecided, 4-agree, 5-strongly agree) for the question "Is this product easy to use?"

    Time frame: 7 days

  9. Participant Recommendation to Other Parents

    Parental agreement on a likert scale (1-strongly disagree, 2-disagree, 3-undecided, 4-agree, 5-strongly agree) for the statement "I would recommend this product to other parents."

    Time frame: 7 days

07

Results

Posted Apr 4, 2024

Participant flow

Participant flow — Overall Study
MilestoneNasal Suction Device: Nose FridaNasal Suction Device: Bulb
Started129
Completed74
Not completed55
Withdrew: Lost to follow-up55

Outcome measures

PrimaryNumber of Emergency Room Visits

Number of emergency room visits for the same respiratory illness within 5 days following discharge, measured via caregiver response on Redcap survey

Time frame:
5 days
Reported as:
Number · number of visits
Number of Emergency Room Visits
number of visitsNasal Suction Device: Nose FridaNasal Suction Device: Bulb
Number of Emergency Room Visits00
PrimaryNumber of Participants Readmitted to Hospital for Respiratory Illness or Dehydration

Number of participants readmitted to Hospital for respiratory illness or dehydration within 5 days following discharge, measured via caregiver response on Redcap survey

Time frame:
5 days
Reported as:
Count of participants · Participants
Number of Participants Readmitted to Hospital for Respiratory Illness or Dehydration
ParticipantsNasal Suction Device: Nose FridaNasal Suction Device: Bulb
Number of Participants Readmitted to Hospital for Respiratory Illness or Dehydration00
SecondaryCaregiver Device Preference

In response to "Which device did you prefer?" on caregiver survey, caregiver may select NoseFrida, Bulb Syringe, Both, or Neither.

Time frame:
5 days

No measurements were reported for this outcome.

SecondaryCaregiver Perception of NoseFrida Device Effectiveness

In response to "Which device was more effective in suctioning your baby's nose?" on caregiver survey, responses using a likert scale (0-NoseFrida less effective, 1-NoseFrida equally effective, 2-NoseFrida more effective). A higher score represents higher caregiver perceived effectiveness of NoseFrida

Time frame:
5 days

No measurements were reported for this outcome.

SecondaryCaregiver Perception of Bulb Device Effectiveness

In response to "Which device was more effective in suctioning your baby's nose?" on caregiver survey, responses using a likert scale (0-Bulb Syringe less effective, 1-Bulb Syringe equally effective, 2-Bulb Syringe more effective). A higher score represents higher caregiver perceived effectiveness of bulb syringe

Time frame:
5 days

No measurements were reported for this outcome.

SecondaryNumber of Days After Discharge Until Respiratory Symptoms Return to Pre-illness Levels

Number of days after discharge until respiratory symptoms (tachypnea, retractions, increased WOB) return to pre-illness levels.

Time frame:
7 days
Reported as:
Mean · days
Number of Days After Discharge Until Respiratory Symptoms Return to Pre-illness Levels
daysNasal Suction Device: Nose FridaNasal Suction Device: Bulb
Number of Days After Discharge Until Respiratory Symptoms Return to Pre-illness Levels1.3 ± 0.6—
SecondaryNumber of Days After Discharge Until Eating/Drinking Returns to Pre-illness Levels

Number of days after discharge until eating/drinking returns to pre-illness levels

Time frame:
7 days
Reported as:
Mean · days
Number of Days After Discharge Until Eating/Drinking Returns to Pre-illness Levels
daysNasal Suction Device: Nose FridaNasal Suction Device: Bulb
Number of Days After Discharge Until Eating/Drinking Returns to Pre-illness Levels1.5 ± 1.21.0 ± 0
SecondaryNumber of Days After Discharge Until Sleeping Returns to Pre-illness Levels

Number of days after discharge until sleeping returns to pre-illness levels

Time frame:
7 days
Reported as:
Mean · days
Number of Days After Discharge Until Sleeping Returns to Pre-illness Levels
daysNasal Suction Device: Nose FridaNasal Suction Device: Bulb
Number of Days After Discharge Until Sleeping Returns to Pre-illness Levels1.0 ± 01.0 ± 0
SecondaryParental Satisfaction on Suction Product Efficacy

Parental satisfaction on a likert scale (1-strongly disagree, 2-disagree, 3-undecided, 4-agree, 5-strongly agree) for the question "Does this product suction babies nose well?"

Time frame:
7 days
Reported as:
Median · score on a scale
Parental Satisfaction on Suction Product Efficacy
score on a scaleNasal Suction Device: Nose FridaNasal Suction Device: Bulb
Parental Satisfaction on Suction Product Efficacy4 (3 to 5)4.5 (3 to 5)
SecondaryParental Satisfaction on Ease of Use

Parental satisfaction on a likert scale (1-strongly disagree, 2-disagree, 3-undecided, 4-agree, 5-strongly agree) for the question "Is this product easy to use?"

Time frame:
7 days
Reported as:
Median · score on a scale
Parental Satisfaction on Ease of Use
score on a scaleNasal Suction Device: Nose FridaNasal Suction Device: Bulb
Parental Satisfaction on Ease of Use4.5 (3 to 5)4.5 (3 to 5)
SecondaryParticipant Recommendation to Other Parents

Parental agreement on a likert scale (1-strongly disagree, 2-disagree, 3-undecided, 4-agree, 5-strongly agree) for the statement "I would recommend this product to other parents."

Time frame:
7 days
Reported as:
Median · score on a scale
Participant Recommendation to Other Parents
score on a scaleNasal Suction Device: Nose FridaNasal Suction Device: Bulb
Participant Recommendation to Other Parents4.5 (4 to 5)4.5 (3 to 5)

Adverse events

Collected over 7 days. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Nasal Suction Device: Nose Frida0/12 (0%)0/12 (0%)0/12 (0%)
Nasal Suction Device: Bulb0/9 (0%)0/9 (0%)0/9 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(months)Nasal Suction Device: Nose FridaNasal Suction Device: BulbTotal
Mean11.3 ± 2.58.5 ± 6.810.1 ± 4.9
Sex: Female, Male
Sex: Female, Male(Participants)Nasal Suction Device: Nose FridaNasal Suction Device: BulbTotal
Female538
Male7613
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Nasal Suction Device: Nose FridaNasal Suction Device: BulbTotal
Count of participants——0
Region of Enrollment
Region of Enrollment(participants)Nasal Suction Device: Nose FridaNasal Suction Device: BulbTotal
United States12921
08

Study locations

1 site
  • Margaret J Menoch, MD
    Royal Oak, Michigan 48073, United States
09

References and documents

Study documents

  • Study protocol · Oct 7, 2020
  • Statistical analysis plan · Jan 4, 2024
  • Informed consent form · Sep 15, 2023

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 4, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04599101
Lead sponsor
William Beaumont Hospitals
Collaborators
Fridababy
Responsible party
Margaret J Menoch, MD (Emergency Medicine Physician, William Beaumont Hospitals) — Principal investigator
First posted
Oct 22, 2020
Start date
Nov 21, 2020
Primary completion
Apr 18, 2023
Completion
Apr 18, 2023
Results posted
Apr 4, 2024
Last update
Apr 4, 2024

Study contacts

Margaret J Menoch
principal investigator · Beaumont

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion